Balyasny Asset Management
AURA icon

Balyasny Asset Management’s Aura Biosciences AURA Stock Holding History

Balyasny Asset Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.73M Buy
+557,654
New +$3.2M ﹤0.01% 1500

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Balyasny Asset Management's AURA Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Aura Biosciences (AURA) in Q1 2026: 557,654 shares worth $3.73M. The stake represents ﹤0.01% of the portfolio and ranks #1500 among its holdings.

126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Balyasny Asset Management held 557,654 shares of Aura Biosciences worth $3.73M as of Q1 2026.
  • Aura Biosciences was a new Balyasny Asset Management position in Q1 2026.
  • Aura Biosciences made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1500 holding.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.